SAN FRANCISCO, Jan. 29, 2026 /PRNewswire/ — Eko Health, a leader in AI-powered cardiac and pulmonary disease detection, today announced the publication of the TRICORDER (Triple Cardiovascular Disease Detection Using an Artificial Intelligence Stethoscope) study in The Lancet, one of the world’s most cited and influential medical journals. Among patients who received an AI stethoscope examination, detection increased 2.3X for heart failure, 3.5X for atrial fibrillation, and 1.9X for valvular heart disease versus standard practice over 12 months, demonstrating that AI-assisted stethoscope exams can meaningfully improve early cardiac disease detection in real-world settings.

Read more here.